AKTX

Akari Therapeutics
AKTX

9 hedge funds and large institutions have $3.25M invested in Akari Therapeutics in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$314K
2
+$43K
3
+$19K
4
Millennium Management
Millennium Management
New York
+$157

Top Sellers

1
-$419K
2
-$86K
3
-$38K
4
LTFS
Ladenburg Thalmann Financial Services
Florida
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.88M
2
$710K
3
$543K
4
$43K
5
$43K
6
$19K
7
$12K
8
–
9
–
10
–
11
–